Establishment Labs Holdings Inc

Establishment Labs Holdings Inc

ESTA

Get informed when a big investor buys or sells

+ Follow
Market Cap$2.59B
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Establishment Labs Holdings IncEstablishment Labs Holdings Inc-59.5--296%12.40.3
$-79.18

Current Fair Value

191.4% downside

Overvalued by 191.4% based on the discounted cash flow analysis.

Share Statistics

Market cap$2.59 Billion
Enterprise Value$2.53 Billion
Dividend Yield$- (-)
Earnings per Share$-1.72
Beta1.07
Outstanding Shares29,622,101

Return

Return on Equity-295.85%ROE
Return on Assets-12.46%
Return on Invested Capital-11.13%

Valuation & Multiples

P/E Ratio-59.55P/E Ratio
PEG168.29PEG
Price to Sales12.37Price to Sales
Price to Book Ratio-Price to Book Ratio
Enterprise Value to Revenue11.01
Enterprise Value to EBIT-84.79
Enterprise Value to Net Income-58
Total Debt to Enterprise0
Debt to Equity0.33Debt to Equity

Revenue Sources

No data

Insider Trades

Last Earnings Call

Report Date
May 11, 2026
EPS Estimate
$-0.36
Average shareholder expectation
Revenue Estimate
$57.47 M
Average shareholder expectation

Next Earnings Call

Expected Date
August 6, 2026
EPS Estimate
$-0.34
Average shareholder expectation
Revenue Estimate
$65.79 M
Average shareholder expectation

Institutional Put/Call Ratio

Market sentiment based on institutional option activity.

Put/Call Ratio0.0000 59.95%
Total Calls- 100.00%
Total Puts- 100.00%

Institutional Ownership

Holdings and activity of institutional investors.

Ownership %0.54% 89.81%
Total Invested$13.82M 99.09%
Investors Holding4 185.00%

ESG Score

No data

About Establishment Labs Holdings Inc

521 employees
CEO: Juan Jose Chacon Quiros

Establishment Labs Holdings Inc. is a global medical technology company focused on women's health, initially in the breast aesthetics and reconstruction market, by designing, developing, manufacturing and marketing an innovative portfoli...